Warimpex Finanz und Beteiligungs : Resolution Proposals marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
English translation of original German version - for convenience purposes only Remuneration report on the remuneration of the members of the Management Board and.
English translation of original German version - for convenience purposes only Remuneration report on the remuneration of the members of the Management Board and.
21st Austria weekly - Marinomed Agrana A1 Telekom 16/04/2024 [pic1]Agrana: Fruit starch sugar company Agrana generated operating profit EBIT of € 151.0 million in its 2023|24 financial year 1 March 2023 to 29 February 2024 which is line with guidance a very significant improvement compared the prior 2022|23: 88.3 million. Earnings per share rose 1.04 prior year: 0.25. Consolidated revenue amounted 3 786.9 3 637.4 As previously communicated Q3 results published January 2024 sees itself confronted an increasingly challenging business environment since fourth quarter and forecasts EBIT for 2024|25 will be significantly below comparable figure 2023|24. This decline already become apparent first 2024|25.Agrana: performance: -0.74% Marinomed: Marinomed
21st Austria weekly - Marinomed CA Immo Vienna Airport RBI 14/02/2024 [pic1]Marinomed: Marinomed Biotech AG generated revenues of € 9.2 m in 2023 the majority which was again recognized through sale Carragelose products. As expected revenue decreased by 18.6 % compared to previous year 2022: 11.3 m. This is primarily related lower order volumes following high stock levels partners. Cash and cash equivalents 2.6 8.2 Compared level at end Q3 2023 € 2.8 m this position remained nearly stable as a result stricter management resumption convertible note funding program with Nice & Green. Marinomed’s top priorities 2024 are partnering lead Marinosolv products maximizing value asset well obtaining market approval for US.Marinomed Biotech: